{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:06:52Z","timestamp":1794258412720,"version":"4.9.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pedneo.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:35:05Z","timestamp":1791387305000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2026.06.013_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1330517","article-title":"Recent findings on drug hypersensitivity in children","volume":"5","author":"Felix","year":"2024","journal-title":"Front Allergy"},{"key":"10.1016\/j.pedneo.2026.06.013_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.pedneo.2026.06.013_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13052-024-01694-x","article-title":"Risk factors for drug hypersensitivity reactions in children","volume":"50","author":"Mori","year":"2024","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.pedneo.2026.06.013_bib4","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaip.2018.02.018","article-title":"The frequency and clinical features of hypersensitivity reactions to antiepileptic drugs in children: a prospective study","volume":"6","author":"Guvenir","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl 3","key":"10.1016\/j.pedneo.2026.06.013_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1528-1157.43.s.3.5.x","article-title":"Children versus adults: pharmacokinetic and adverse-effect differences","volume":"43","author":"Anderson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.pedneo.2026.06.013_bib6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0009-9236(98)90093-5","article-title":"Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef","volume":"63","author":"Kearns","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2026.06.013_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/adc.2008.154377","article-title":"Adverse drug reactions in childhood: a review of prospective studies and safety alerts","volume":"94","author":"Clavenna","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2026.06.013_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0895-4356(00)00190-6","article-title":"Adverse drug reactions in children reported by means of the yellow card in Spain","volume":"53","author":"Morales-Olivas","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/11587540-000000000-00000","article-title":"Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase","volume":"34","author":"Star","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.pedneo.2026.06.013_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/11597920-000000000-00000","article-title":"Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study","volume":"35","author":"Rashed","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.pedneo.2026.06.013_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2017.02.013","article-title":"Severe cutaneous adverse drug reactions in pediatric patients: a multicenter Study","volume":"5","author":"Dibek Misirlioglu","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pedneo.2026.06.013_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphar.2017.00030","article-title":"Reported adverse drug reactions in infants: a nationwide analysis in Malaysia","volume":"8","author":"Rosli","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.892574","article-title":"Recommendations on off-label Drug Use in Pediatric Guidelines","volume":"13","author":"Meng","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib17","first-page":"e24","article-title":"Impact of sample size on variation of adverse events and preventable adverse events: systematic review on epidemiology and contributing factors","volume":"19","author":"Lessing","year":"2010","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.pedneo.2026.06.013_bib18","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2026.06.013_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","article-title":"Case-non-case studies: principle, methods, bias and interpretation","volume":"74","author":"Faillie","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.pedneo.2026.06.013_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00002018-199716060-00002","article-title":"Principles of signal detection in pharmacovigilance","volume":"16","author":"Meyboom","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.pedneo.2026.06.013_bib22","first-page":"60","article-title":"Measuring medicine use: applying ATC\/DDD methodology to real-world data","volume":"9","author":"Hollingworth","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.pedneo.2026.06.013_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"key":"10.1016\/j.pedneo.2026.06.013_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1096366","article-title":"A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications","volume":"14","author":"Shan","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41467-023-35808-6","article-title":"Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pedneo.2026.06.013_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1124\/dmd.122.000876","article-title":"Pharmacokinetic modeling of warfarin \u0406 - model-based analysis of warfarin enantiomers with a target mediated drug disposition model reveals CYP2C9 genotype-dependent drug-drug interactions of S-Warfarin","volume":"50","author":"Cheng","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pedneo.2026.06.013_bib28","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.pedneo.2026.06.013_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jnr.23884","article-title":"A general theory of sexual differentiation","volume":"95","author":"Arnold","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pedneo.2026.06.013_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijd.IJD_583_17","article-title":"Management of Stevens-Johnson syndrome-toxic Epidermal Necrolysis: looking beyond Guidelines","volume":"63","author":"Kumar","year":"2018","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib31","first-page":"82","article-title":"Erythema multiforme: recognition and management","volume":"100","author":"Trayes","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pedneo.2026.06.013_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5414\/CP203798","article-title":"Polypharmacy in three different spontaneous adverse drug event databases","volume":"58","author":"Mabuchi","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2026.06.013_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5114\/ait.2021.103628","article-title":"Drug utilisation in adult, paediatric and neonatal intensive care units, with an emphasis on systemic antimicrobials","volume":"53","author":"Sridharan","year":"2021","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.pedneo.2026.06.013_bib34","first-page":"7","article-title":"IV infiltration and latex allergy in an infant: early recognition is key to prevent lasting disability","volume":"3","author":"Lucke-Wold","year":"2017","journal-title":"Clin Pediatr Dermatol"},{"key":"10.1016\/j.pedneo.2026.06.013_bib35","doi-asserted-by":"crossref","DOI":"10.3171\/CASE24589","article-title":"Spontaneous subaponeurotic fluid collection in an infant: illustrative case","volume":"9","author":"Mohamed","year":"2025","journal-title":"J Neurosurg Case Lessons"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957226001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957226001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:31:56Z","timestamp":1792063916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957226001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S1875957226001555"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2026.06.013","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}